Table 2.
Overview of the studies including patients treated with PN + AGIR.
| Author (Year) | Country | Period of Study | Study Population | Number of Patients Weaning of PN |
|---|---|---|---|---|
| Fitzgerald (2019) | Canada | 2003–2016 | 36 | 15 |
| Shah (2019) | USA | 2004–2014 | 22 | 11 |
| Mutanen (2019) | Finland | 2003–2014 | 15 | 1 |
| Pederiva (2018) | UK | 2002–2012 | 43 | 25 |
| Coletta (2017) | UK | 2012–2017 | 5 | 0 |
| Barrett 2017) | USA | 2003–2014 | 17 | 6 |
| Wester (2016) | Finland | 2004–2015 | 27 | 16 |
| Bueno (2015) | Spain | 2005–2013 | 3 | 1 |
| Oh (2014) | USA | 2004–2011 | 15 | 5 |
| Mercer (2014) | USA | 2006–2011 | 51 | 24 |
| Javid (2013) | USA | 2004–2011 | 16 | 9 |
| Wales (2013) | Canada | 2009–2011 | 5 | 2 |
| Almond (2013) | UK | 2004–2011 | 8 | 7 |
| Kang (2012) | USA | 2002–2011 | 16 | 8 |
| Leung (2012) | Hong Kong | 2007–2010 | 4 | 1 |
| Lourenco (2012) | Portugal | 2006–2008 | 3 | 2 |
| Ching (2009) | USA | 2002–2008 | 16 | 6 |
| Wales (2007) | Canada | 2003–2006 | 14 | 7 |
| Duggan (2006) | USA | 2002–2014 | 4 | 2 |
PN: Parenteral nutrition; AGIR: autologous reconstructive gastro-intestinal surgery.